425 1 g98957e8vk.htm IVAX CORPORATION IVAX Corporation
 

 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) December 22, 2005
IVAX Corporation
 
(Exact name of registrant as specified in its charter)
         
Florida   1-09623   16-1003559
         
(State or other jurisdiction of
incorporation)
  (Commission file number)   (I.R.S. Employer
Identification Number)
     
4400 Biscayne Boulevard,    
Miami, Florida   33137
     
(Address of principal executive offices)   (Zip Code)
(305) 575-6000
 
(Registrant’s telephone number, including area code)
Not Applicable
 
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):
x   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o   Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o   Pre-commencement communications pursuant to Rule 13e4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 

 


 

Item 8.01 Other Events
     On December 22, 2005, IVAX Corporation (“IVAX”) issued a joint press release with Teva Pharmaceutical Industries Limited (“Teva”) announcing the anticipated closing date in connection with IVAX’ pending acquisition by Teva. A copy of the press release is attached hereto as exhibit 99.1 to this Current Report on Form 8-K.
Item 9.01 Financial Statements and Exhibits
(c) Exhibits
         
Exhibit No.   Description
  99.1    
Press Release issued December 22, 2005.

2


 

SIGNATURES
     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
         
  IVAX CORPORATION
 
 
  By:   /s/ Steven D. Rubin    
    Name:   Steven D. Rubin   
    Title:   Senior Vice President, General Counsel and Secretary   
 
Date: December 22, 2005

3